All Stories

  1. Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome
  2. Incremental and Twice-Weekly Hemodialysis Program in Practice
  3. The Effects of High-Protein Diets on Kidney Health and Longevity
  4. Kidney Health for Everyone Everywhere – From Prevention to Detection and Equitable Access to Care
  5. Performance characteristics of profiling methods and the impact of inadequate case-mix adjustment
  6. Impact of case-mix measurement error on estimation and inference in profiling of health care providers
  7. Modeling time-varying effects of multilevel risk factors of hospitalizations in patients on dialysis
  8. Effects of Bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease
  9. Vascular access placement and mortality in elderly incident hemodialysis patients
  10. Adequacy of Plant-Based Proteins in Chronic Kidney Disease
  11. Red blood cell distribution width and mortality and hospitalizations in peritoneal dialysis patients
  12. Rejoinder: Time-dynamic profiling with application to hospital readmission among patients on dialysis
  13. Time-dynamic profiling with application to hospital readmission among patients on dialysis
  14. Inverse Association Between Serum Non–High‐Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis
  15. Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease
  16. High and low estimated glomerular filtration rates are associated with adverse outcomes in patients undergoing surgery for gastrointestinal malignancies
  17. Impact of residual kidney function on hemodialysis adequacy and patient survival
  18. Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
  19. Association of Pre-ESRD Serum Calcium With Post-ESRD Mortality Among Incident ESRD Patients: A Cohort Study
  20. What we do and do not know about women and kidney diseases; questions unanswered and answers unquestioned: reflection on World Kidney Day and International Woman’s Day
  21. In response to ‘benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease’
  22. Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters
  23. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease
  24. Increments in serum high-density lipoprotein cholesterol over time are not associated with improved outcomes in incident hemodialysis patients
  25. US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States
  26. Potentially Avoidable Readmissions in United States Hemodialysis Patients
  27. Women and Kidney Diseases: Questions Unanswered and Answers Unquestioned
  28. History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study
  29. Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function
  30. What we do and do not know about women and kidney diseases; questions unanswered and answers unquestioned: reflection on World Kidney Day and International Women’s Day
  31. Establishing a clinical phenotype for cachexia in end stage kidney disease – study protocol
  32. What We Do and Do Not Know About Women and Kidney Diseases; Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Woman’s Day
  33. Nutritional Management of Chronic Kidney Disease
  34. Women and kidney disease: reflections on World Kidney Day 2018
  35. Women and kidney disease: reflections on World Kidney Day 2018
  36. Association of Ultrafiltration Rate with Mortality in Incident Hemodialysis Patients
  37. Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism
  38. Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease
  39. Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide
  40. Serum uric acid and mortality risk among maintenance hemodialysis patients
  41. There's no place like home: 35-year patient survival on home hemodialysis
  42. Further clarifying the relationship between metformin, acute kidney injury and lactic acidosis
  43. Impact of Obesity on Modality Longevity, Residual Kidney Function, Peritonitis, and Survival Among Incident Peritoneal Dialysis Patients
  44. Thoracic Quantitative Computed Tomography (QCT) Can Sensitively Monitor Bone Mineral Metabolism
  45. Serum high density lipoprotein cholesterol level and risk of death: let’s avoid the extremes
  46. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial
  47. Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials
  48. nutritional support for patients with kidney disease
  49. The Authors’ Reply
  50. Changes in Albuminuria and Subsequent Risk of Incident Kidney Disease
  51. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
  52. Pre-end-stage renal disease visit-to-visit systolic blood pressure variability and post-end-stage renal disease mortality in incident dialysis patients
  53. Incremental and Once- to Twice-Weekly Hemodialysis: From Experience to Evidence
  54. Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient
  55. Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function
  56. Blood Pressure Before Initiation of Maintenance Dialysis and Subsequent Mortality
  57. Race, Serum Potassium, and Associations With ESRD and Mortality
  58. Dietary Approaches in the Management of Diabetic Patients with Kidney Disease
  59. Association of pre-operative estimated GFR on post-operative pulmonary complications in laparoscopic surgeries
  60. Diabetes mellitus: Complex interplay between metformin, AKI and lactic acidosis
  61. Thyroid Status, Quality of Life, and Mental Health in Patients on Hemodialysis
  62. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis
  63. Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization
  64. A brief review of intradialytic hypotension with a focus on survival
  65. Association of Glycemic Status During Progression of Chronic Kidney Disease With Early Dialysis Mortality in Patients With Diabetes
  66. Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
  67. Longitudinal Associations among Renal Urea Clearance–Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis
  68. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function
  69. Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study
  70. Sex Differences in Hospitalizations with Maintenance Hemodialysis
  71. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients
  72. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease
  73. Obesity and kidney disease: hidden consequences of the epidemic
  74. Introduction to the Critical Balance - Residual Kidney Function and Incremental Transition to Dialysis
  75. Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling
  76. Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA
  77. Prediction equation for calculating residual kidney urea clearance using urine collections for different hemodialysis treatment frequencies and interdialytic intervals
  78. Incremental Hemodialysis: The University of California Irvine Experience
  79. Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society
  80. Modeling longitudinal data and its impact on survival in observational nephrology studies: tools and considerations
  81. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
  82. Obesity and Kidney Disease: Hidden Consequences of the Epidemic
  83. The Obesity Paradox in Kidney Disease: How to Reconcile It With Obesity Management
  84. Examining the Proportion of Dietary Phosphorus From Plants, Animals, and Food Additives Excreted in Urine
  85. Obesity and kidney disease: Hidden consequences of the epidemic
  86. Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients
  87. Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA
  88. Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease
  89. DASH-ing toward improved renal outcomes: when healthy nutrition prevents incident chronic kidney disease
  90. Obesity and kidney disease: hidden consequences of the epidemic
  91. Obesity and kidney disease: hidden consequences of the epidemic
  92. Obesity and kidney disease: hidden consequences of the epidemic
  93. Reply to “Is mean platelet volume a prognostic marker for hemodialysis patients?”
  94. Thyroid Status and Mortality in a Prospective Hemodialysis Cohort
  95. Obesity and Kidney Disease: Hidden Consequences of the Epidemic
  96. Serum uric acid, protein intake and mortality in hemodialysis patients
  97. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis
  98. Dietary protein intake and chronic kidney disease
  99. Intradialytic Parenteral Nutrition and Intraperitoneal Nutrition
  100. Concurrence of Serum Creatinine and Albumin With Lower Risk for Death in Twice-Weekly Hemodialysis Patients
  101. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort
  102. Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients
  103. Clinical Aspects of Natural and Added Phosphorus in Foods
  104. Nutritional Management in Peritoneal Dialysis
  105. Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients
  106. Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis
  107. Effect of Age on the Association of Vascular Access Type with Mortality in a Cohort of Incident End-Stage Renal Disease Patients
  108. Early Mortality Associated with Inpatient versus Outpatient Hemodialysis Initiation in a Large Cohort of US Veterans with Incident End-Stage Renal Disease
  109. History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology
  110. Insights from Screening a Racially and Ethnically Diverse Population for Chronic Kidney Disease
  111. Association between Testosterone and Mortality Risk among U.S. Males Receiving Dialysis
  112. Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort
  113. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome
  114. Pre-ESRD Dementia and Post-ESRD Mortality in a Large Cohort of Incident Dialysis Patients
  115. Use of Phosphorus Binders among Non-Dialysis Chronic Kidney Disease Patients and Mortality Outcomes
  116. Warfarin Use and Increased Mortality in End-Stage Renal Disease
  117. Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy
  118. Association of Restless Legs Syndrome With Incident Parkinson’s Disease
  119. Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease
  120. Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events
  121. Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
  122. Changes in urine volume and serum albumin in incident hemodialysis patients
  123. Constipation and Incident CKD
  124. Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis
  125. Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its Association With Mortality Among Hemodialysis Patients
  126. Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort
  127. Dietary Management of Incremental Transition to Dialysis Therapy: Once-Weekly Hemodialysis Combined With Low-Protein Diet
  128. Racial–ethnic disparities in mortality and kidney transplant outcomes among pediatric dialysis patients
  129. Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data
  130. Serum Magnesium Levels and Hospitalization and Mortality in Incident Peritoneal Dialysis Patients: A Cohort Study
  131. Racial Differences in Survival of Incident Home Hemodialysis and Kidney Transplant Patients
  132. Mean platelet volume and mortality risk in a national incident hemodialysis cohort
  133. Predialysis Cardiovascular Disease Medication Adherence and Mortality After Transition to Dialysis
  134. Survival of Elderly Adults Undergoing Incident Home Hemodialysis and Kidney Transplantation
  135. Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease
  136. Conservatism strikes back: later is better than earlier dialysis for acute kidney injury
  137. Preservation of residual kidney function in hemodialysis patients: reviving an old concept
  138. Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study
  139. Development and evaluation of a retroperitoneal dialysis porcine model
  140. Pain and Kidney Function Decline and Mortality: A Cohort Study of US Veterans
  141. Age, Race and Cardiovascular Outcomes in African American Veterans
  142. North American experience with Low protein diet for Non-dialysis-dependent chronic kidney disease
  143. Comparisons of sleep apnoea rate and outcomes among patients with resistant and non-resistant hypertension
  144. Moderator's view: Higher serum bicarbonate in dialysis patients is protective
  145. Adherence to ketoacids/essential amino acids-supplemented low protein diets and new indications for patients with chronic kidney disease
  146. Predictive Score for Posttransplantation Outcomes
  147. Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients
  148. Erratum to “Averting the legacy of kidney disease–Focus on childhood” [Nephrol. Ther. 12 (1) (2016) 1–5]
  149. Red Cell Distribution Width and Mortality in Hemodialysis Patients
  150. Reply to comment on World Kidney Day 2016: averting the legacy of kidney disease—focus on childhood
  151. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
  152. Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression
  153. Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis Patients
  154. Averting the legacy of kidney disease
  155. Errata do “Em tempo: Evitando as consequências da doença renal − foco na infância” [Rev Paul Pediatr. 2016;34(1):5‐10]
  156. Acute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data
  157. Erratum to “In time: averting the legacy of kidney disease – focus on childhood” [Rev. Paul. Pediatr. 34 (1) (2016) 5–10]
  158. Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes
  159. The dual roles of obesity in chronic kidney disease
  160. Reexamining the Phosphorus–Protein Dilemma: Does Phosphorus Restriction Compromise Protein Status?
  161. Association of Body Mass Index with Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis
  162. Averting the legacy of kidney disease
  163. Corrigendum to World Kidney Day 2016. Averting the legacy of kidney disease – focus on childhood [Pediatria Polska (2016);91(2)105–110]
  164. Averting the legacy of kidney disease: focus on childhood
  165. Yet Another Vitamin D Analogue for the Management of Secondary Hyperparathyroidism: A Triton among the Minnows?
  166. Erratum to: Averting the legacy of kidney disease: focus on childhood
  167. Age and Outcomes Associated with BP in Patients with Incident CKD
  168. Día Mundial del Riñón 2016. Prevención del legado de la nefropatía, con enfoque en la niñez
  169. Averting the legacy of kidney disease – focus on childhood
  170. Averting the legacy of kidney disease – focus on childhood
  171. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly
  172. Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort
  173. Response to Letter Regarding Article, “Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans”
  174. Averting the Legacy of Kidney Disease—Focus on Childhood
  175. Averting the legacy of kidney disease: focus on childhood
  176. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients
  177. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States
  178. Averting the legacy of kidney disease—focus on childhood
  179. Averting the legacy of kidney disease — focus on childhood
  180. World Kidney Day 2016: Averting the Legacy of Kidney Disease—Focus on Childhood
  181. World Kidney Day 2016: Averting the legacy of kidney disease. Focus on childhood
  182. Em tempo: evitando as consequências da doença renal – foco na infância
  183. Averting the Legacy of Kidney Disease-Focus on Childhood
  184. In time: averting the legacy of kidney disease – focus on childhood
  185. New Options for Iron Supplementation in Maintenance Hemodialysis Patients
  186. World Kidney Day 2016. Averting the legacy of kidney disease – Focus on childhood
  187. Día Mundial del Riñón 2016: evitar el legado de la enfermedad renal. Enfoque en la niñez
  188. Averting the legacy of kidney disease: focus on childhood
  189. Back to the future: restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health
  190. World Kidney Day 2016 Averting The Legacy of Kidney Disease-Focus On Childhood
  191. Averting the Legacy of Kidney Disease—Focus on Childhood
  192. Averting the legacy of kidney disease: focus on childhood
  193. Averting the legacy of kidney disease–Focus on childhood
  194. World Kidney Day 2016: Averting the legacy of kidney disease—focus on childhood
  195. Association of Slopes of Estimated Glomerular Filtration Rate With Post–End-Stage Renal Disease Mortality in Patients With Advanced Chronic Kidney Disease Transitioning to Dialysis
  196. World kidney day 2016 Averting the legacy of kidney disease – focus on childhood
  197. Averting the Legacy of Kidney Disease: Focus on Childhood
  198. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure
  199. Vascular access in home dialysis
  200. Kidney transplantation in obese patients
  201. Averting the Legacy of Kidney Disease - Focus on Childhood
  202. Averting the legacy of kidney disease - Focus on childhood
  203. Editorial: World Kidney Day 2016: Averting the Legacy of Kidney Disease--Focus on Childhood
  204. Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
  205. Lean Body Mass and Survival in Hemodialysis Patients and the Roles of Race and Ethnicity
  206. Averting the Legacy of Kidney Disease - Focus on Childhood
  207. Averting the Legacy of Kidney Disease - Focus on Childhood
  208. Averting the Legacy of Kidney Disease - Focus on Childhood
  209. Averting the legacy of kidney disease - focus on childhood
  210. Averting the legacy of kidney disease: Focus on childhood
  211. Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality
  212. Carrying a heavier weight is healthy: Obesity-reinforced fitness hypothesis in metabolically healthy obesity
  213. Hypomagnesemia and Mortality in Incident Hemodialysis Patients
  214. Restricting Metformin in CKD: Continued Caution Warranted
  215. Examining the robustness of the obesity paradox in maintenance hemodialysis patients: a marginal structural model analysis
  216. What Is Known and Unknown About Twice-Weekly Hemodialysis
  217. Request for regulatory guidance for cancer cachexia intervention trials
  218. Association of Pre-Operative Albuminuria with Post-Operative Outcomes after Coronary Artery Bypass Grafting
  219. Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal Syndrome
  220. Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population
  221. Association of Body Mass Index with Clinical Outcomes in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis
  222. Peritoneal Equilibration Test and Patient Outcomes
  223. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury
  224. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
  225. Pre-dialysis serum sodium and mortality in a national incident hemodialysis cohort
  226. Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US VeteransCLINICAL PERSPECTIVE
  227. Association of incident restless legs syndrome with outcomes in a large cohort of US veterans
  228. Association of aspartate aminotransferase with mortality in hemodialysis patients
  229. Association of age and BMI with kidney function and mortality: a cohort study
  230. Cardiovascular and Renal Outcomes Trials—Is There a Difference?
  231. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension
  232. Implications of the long interdialytic gap: a problem of excess accumulation vs. excess removal?
  233. Why Is the Association of Phosphorus and FGF23 with Mortality Stronger in African-American Hemodialysis Patients
  234. Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing
  235. Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease
  236. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients
  237. Metformin in chronic kidney disease: more harm than help?
  238. Nutrition Intervention for Advanced Stages of Diabetic Kidney Disease
  239. Overcoming the Body Mass Index as a Barrier in Kidney Transplantation
  240. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States
  241. Self-Reported Interview-Assisted Diet Records Underreport Energy Intake in Maintenance Hemodialysis Patients
  242. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans
  243. Changes in Pulse Pressure during Hemodialysis Treatment and Survival in Maintenance Dialysis Patients
  244. The Gut as a Source of Inflammation in Chronic Kidney Disease
  245. Latest consensus and update on protein-energy wasting in chronic kidney disease
  246. Comparison of the malnutrition–inflammation score in chronic kidney disease patients and kidney transplant recipients
  247. Is There a Role for Ketoacid Supplements in the Management of CKD?
  248. Niacin and Progression of CKD
  249. Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research
  250. Haemodialysis-induced hypoglycaemia and glycaemic disarrays
  251. Association of Thyroid Functional Disease With Mortality in a National Cohort of Incident Hemodialysis Patients
  252. Association of Height with Mortality in Patients Undergoing Maintenance Hemodialysis
  253. Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans
  254. Factors Affecting Daily Physical Activity and Physical Performance in Maintenance Dialysis Patients
  255. Dietary Restrictions in Dialysis Patients: Is There Anything Left to Eat?
  256. Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis
  257. Socioeconomic Disparities in Chronic Kidney Disease
  258. Using a Web-Based Nutrition Algorithm in Hemodialysis Patients
  259. Association of Serum Lipids with Outcomes in Hispanic Hemodialysis Patients of the West versus East Coasts of the United States
  260. Body Site Staphylococcus aureus Colonization among Maintenance Hemodialysis Patients
  261. Impact of Non-Adherence on Renal and Cardiovascular Outcomes in US Veterans
  262. Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
  263. To Eat or Not to Eat—International Experiences With Eating During Hemodialysis Treatment
  264. Outcomes of Cephalic Arch Stenosis With and Without Stent Placement after Percutaneous Balloon Angioplasty in Hemodialysis Patients
  265. Alkaline phosphatase: Better than PTH as a marker of cardiovascular and bone disease?
  266. Diabetic Kidney Disease: A Report From an ADA Consensus Conference
  267. Error in Byline
  268. Plasma Renin Activity and Its Association With Ischemic Heart Disease, Congestive Heart Failure, and Cerebrovascular Disease in a Large Hypertensive Cohort
  269. Diabetic Kidney Disease: A Report From an ADA Consensus Conference
  270. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease
  271. Protein-energy wasting and uremic failure to thrive in children with chronic kidney disease: They are not small adults
  272. Dialysate Bicarbonate and the Risk of Death
  273. Observational Modeling of Strict vs Conventional Blood Pressure Control in Patients With Chronic Kidney Disease
  274. Correspondence: Authors' Reply
  275. Cerebral microbleeds and cognitive decline in a hemodialysis patient: Case report and review of literature
  276. Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients?
  277. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series
  278. Association of Medical Treatment Nonadherence With All-Cause Mortality in Newly Treated Hypertensive US VeteransNovelty and Significance
  279. To Legitimize the Contentious Obesity Paradox
  280. Impact of Achieved Blood Pressures on Mortality Risk and End-Stage Renal Disease Among a Large, Diverse Hypertension Population
  281. Twice-Weekly and Incremental Hemodialysis Treatment for Initiation of Kidney Replacement Therapy
  282. Critical Appraisal of Biomarkers of Dietary Intake and Nutritional Status in Patients Undergoing Dialysis
  283. Balancing Nutrition and Serum Phosphorus in Maintenance Dialysis
  284. Relation Between Anxiety, Depression, and Physical Activity and Performance in Maintenance Hemodialysis Patients
  285. Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
  286. Daily physical activity and physical function in adult maintenance hemodialysis patients
  287. Let us give twice-weekly hemodialysis a chance: revisiting the taboo
  288. Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures
  289. Clinical Uses of 1-Alpha-Hydroxy-Ergocalciferol
  290. Bone and mineral disorders after kidney transplantation: Therapeutic strategies
  291. Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients
  292. Effect of Age and Dialysis Vintage on Obesity Paradox in Long-term Hemodialysis Patients
  293. Association of Body Mass Index with Outcomes in Patients with CKD
  294. Is an Increased Serum Bicarbonate Concentration during Hemodialysis Associated with an Increased Risk of Death?
  295. Muscle wasting disease: a proposal for a new disease classification
  296. Updates on the Management of Diabetes in Dialysis Patients
  297. Urinary Lithogenic Risk Profile in Recurrent Stone Formers With Hyperoxaluria: A Randomized Controlled Trial Comparing DASH (Dietary Approaches to Stop Hypertension)-Style and Low-Oxalate Diets
  298. Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients
  299. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients
  300. Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
  301. Development and Analytical Evaluation of a Spectrophotometric Procedure for the Quantification of Different Types of Phosphorus in Meat Products
  302. Revisiting the association between altitude and mortality in dialysis patients
  303. Risk of chronic kidney disease after cancer nephrectomy
  304. Comparative Mortality-Predictability Using Alkaline Phosphatase and Parathyroid Hormone in Patients on Peritoneal Dialysis and Hemodialysis
  305. Outcomes of Kidney Replacement Therapies
  306. Body Mass Index and Mortality in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis
  307. Obesity Paradox in End-Stage Kidney Disease Patients
  308. Glycated Hemoglobin and Risk of Death in Diabetic Patients Treated With Hemodialysis: A Meta-analysis
  309. Time to Revisit the Role of Renal Dietitian in the Dialysis Unit
  310. Association of Initial Twice-Weekly Hemodialysis Treatment with Preservation of Residual Kidney Function in ESRD Patients
  311. Dose of Hemodialysis and Survival: A Marginal Structural Model Analysis
  312. Impact of Age, Race and Ethnicity on Dialysis Patient Survival and Kidney Transplantation Disparities
  313. The Relationship Between Ultraviolet Light Exposure and Mortality in Dialysis Patients
  314. Association of pre-transplant blood pressure with post-transplant outcomes
  315. Protein-Energy Wasting
  316. Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients
  317. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism
  318. Obesity That Makes Kidney Cancer More Likely but Helps Fight It More Strongly
  319. Association of Serum Phosphorus Concentration With Mortality in Elderly and Nonelderly Hemodialysis Patients
  320. Introduction
  321. Case 23-2013: A 54-Year-Old Woman with Metformin Toxicity
  322. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease
  323. Association of Vascular Access Type with Inflammatory Marker Levels in Maintenance Hemodialysis Patients
  324. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival
  325. Characteristics of Resistant Hypertension in a Large, Ethnically Diverse Hypertension Population of an Integrated Health System
  326. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial
  327. Dialysis Initiation: What's the Rush?
  328. PD First: Peritoneal Dialysis as the Default Transition to Dialysis Therapy
  329. Timing of Return to Dialysis in Patients with Failing Kidney Transplants
  330. Infrequent Dialysis: A New Paradigm for Hemodialysis Initiation
  331. Changes in Body Weight and Subsequent Mortality: Are We Any Closer to Knowing How to Deal with Obesity in ESRD?
  332. Overweight, Mortality and Survival
  333. Racial Disparities in Kidney Disease Outcomes
  334. Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease
  335. Nephrologist Caseload and Hemodialysis Patient Survival in an Urban Cohort
  336. Survival Advantage in Black Versus White Men With CKD: Effect of Estimated GFR and Case Mix
  337. Racial Differences in Estimated GFR Decline, ESRD, and Mortality in an Integrated Health System
  338. Impact of age on survival predictability of bone turnover markers in hemodialysis patients
  339. Case 23-2013
  340. Mechanism and novel therapeutic approaches to wasting in chronic disease
  341. Ecstacy-associated hyponatremia: why are women at risk?
  342. Is Iron Maintenance Therapy Better Than Load and Hold?
  343. Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients
  344. Why cachexia kills: examining the causality of poor outcomes in wasting conditions
  345. Nutritional predictors of early mortality in incident hemodialysis patients
  346. Low Protein Nitrogen Appearance as a Surrogate of Low Dietary Protein Intake Is Associated with Higher All-Cause Mortality in Maintenance Hemodialysis Patients
  347. Patient education for phosphorus management in chronic kidney disease
  348. Mortality Predictability of Body Size and Muscle Mass Surrogates in Asian vs White and African American Hemodialysis Patients
  349. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy1,3
  350. Let Them Eat During Dialysis: An Overlooked Opportunity to Improve Outcomes in Maintenance Hemodialysis Patients
  351. Role of HDL Dysfunction in End-Stage Renal Disease: A Double-Edged Sword
  352. World Renal Nutrition Week Congress: From Hawaii to Germany
  353. Outcomes Associated With Microalbuminuria
  354. Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function
  355. Cachexia as a major public health problem: frequent, costly, and deadly
  356. Recipient-related predictors of kidney transplantation outcomes in the elderly
  357. Etiology of the Protein-Energy Wasting Syndrome in Chronic Kidney Disease: A Consensus Statement From the International Society of Renal Nutrition and Metabolism (ISRNM)
  358. Management of Natural and Added Dietary Phosphorus Burden in Kidney Disease
  359. High-density lipoprotein in uremic patients: metabolism, impairment, and therapy
  360. Protein Carbamylation Predicts Mortality in ESRD
  361. Correlates of parathyroid hormone concentration in hemodialysis patients
  362. Comparing Mortality of Peritoneal and Hemodialysis Patients in the First 2 Years of Dialysis Therapy: A Marginal Structural Model Analysis
  363. Using Hemoglobin A1c to Derive Mean Blood Glucose in Peritoneal Dialysis Patients
  364. Preface
  365. Dedication
  366. Erratum on the BEACON Study Editorial
  367. Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease
  368. Nutritional Management of Maintenance Hemodialysis Patients
  369. Nutritional Management of Renal Disease
  370. Protein-Energy Wasting as a Risk Factor of Morbidity and Mortality in Chronic Kidney Disease
  371. Significance of Interdialytic Weight Gain versus Chronic Volume Overload: Consensus Opinion
  372. The Extinguished BEACON of Bardoxolone: Not a Monday Morning Quarterback Story
  373. Frailty and Protein-Energy Wasting in Elderly Patients with End Stage Kidney Disease
  374. Cardiorenal syndrome: pathophysiology and potential targets for clinical management
  375. Developing an HbA1c-Based Equation to Estimate Blood Glucose in Maintenance Hemodialysis Patients
  376. Nutritional and Inflammatory Axis of Racial Survival Disparities
  377. Serum Adiponectin Levels and Mortality after Kidney Transplantation
  378. Dialysis Modality and Correction of Uremic Metabolic Acidosis: Relationship with All-Cause and Cause-Specific Mortality
  379. Novel Differential Measurement of Natural and Added Phosphorus in Cooked Ham With or Without Preservatives
  380. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients
  381. Is chronic hyponatremia a novel risk factor for hip fracture in the elderly?
  382. Zero-Mismatch Deceased-Donor Kidney Versus Simultaneous Pancreas-Kidney Transplantation
  383. Administered paricalcitol dose and survival in hemodialysis patients: A marginal structural model analysis
  384. Association of coronary artery calcium score and vascular dysfunction in long‐term hemodialysis patients
  385. Association of Pre-Kidney Transplant Markers of Mineral and Bone Disorder with Post-Transplant Outcomes
  386. Association of Depression and Antidepressant Use with Mortality in a Large Cohort of Patients with Nondialysis-Dependent CKD
  387. Racial Survival Paradox of Dialysis Patients: Robust and Resilient
  388. Donor race and outcomes in kidney transplant recipients
  389. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature
  390. Management of mineral and bone disorder after kidney transplantation
  391. Relationship between obesity and pulse pressure in children: results of the National Health and Nutrition Survey (NHANES) 1988–1994
  392. Accuracy and Limitations of the Diagnosis of Malnutrition in Dialysis Patients
  393. A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: A1C remains the gold standard outcome predictor in diabetic dialysis patients
  394. Correlates of low hemoglobin A1c in maintenance hemodialysis patients
  395. Reimbursement of Dialysis: A Comparison of Seven Countries
  396. Age and the Associations of Living Donor and Expanded Criteria Donor Kidneys With Kidney Transplant Outcomes
  397. Vitamin-D-Rezeptor-Aktivierung bei chronischer Niereninsuffizienz
  398. Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin
  399. Glycemic Control in Diabetic Dialysis Patients and the Burnt-Out Diabetes Phenomenon
  400. Serum Potassium and Cause-Specific Mortality in a Large Peritoneal Dialysis Cohort
  401. Comparing Mandated Health Care Reforms: The Affordable Care Act, Accountable Care Organizations, and the Medicare ESRD Program
  402. Toward More Accurate Detection and Risk Stratification of Chronic Kidney Disease
  403. Relationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain of ESRD patients
  404. Examining Associations of Circulating Endotoxin With Nutritional Status, Inflammation, and Mortality in Hemodialysis Patients
  405. Estimated glomerular filtration rate at reinitiation of dialysis and mortality in failed kidney transplant recipients
  406. Relative contributions of inflammation and inadequate protein intake to hypoalbuminemia in patients on maintenance hemodialysis
  407. Association of pre-transplant erythropoiesis-stimulating agent responsiveness with post-transplant outcomes
  408. Considerations in the optimal preparation of patients for dialysis
  409. Does AKI Truly Lead to CKD?
  410. Mortality Prediction by Surrogates of Body Composition: An Examination of the Obesity Paradox in Hemodialysis Patients Using Composite Ranking Score Analysis
  411. Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients
  412. Enter the dragon: a Chinese epidemic of chronic kidney disease?
  413. Cardiorenal syndrome and vitamin D receptor activation in chronic kidney disease
  414. Plasma Renin Activity (PRA) Levels and Antihypertensive Drug Use in a Large Healthcare System
  415. Timing of dialysis initiation in transplant-naive and failed transplant patients
  416. Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes: A 6-Year Cohort Study
  417. The Crossroad of RAAS Modulation, Inflammation, and Oxidative Stress in Dialysis Patients: Light at the End of the Tunnel?
  418. Hyponatremia, Hypernatremia, and Mortality in Patients With Chronic Kidney Disease With and Without Congestive Heart Failure
  419. Uremic Plasma Impairs Barrier Function and Depletes the Tight Junction Protein Constituents of Intestinal Epithelium
  420. Mortality Associated with Dose Response of Erythropoiesis-Stimulating Agents in Hemodialysis versus Peritoneal Dialysis Patients
  421. Nutrition and malnutrition
  422. Anxiety and Depression in Maintenance Dialysis Patients: Preliminary Data of a Cross-sectional Study and Brief Literature Review
  423. Nephrology and Nutrition Leaders Coming to Hawaii for the World Renal Nutrition Week: Why is the 16th Congress in Renal Nutrition and Metabolism in Honolulu, Hawai’i, June 2012, Worth Attending?
  424. Observational Studies Versus Randomized Controlled Trials: Avenues to Causal Inference in Nephrology
  425. Paricalcitol Versus Ergocalciferol for Secondary Hyperparathyroidism in CKD Stages 3 and 4: A Randomized Controlled Trial
  426. Association of Hypo- and Hyperkalemia with Disease Progression and Mortality in Males with Chronic Kidney Disease: The Role of Race
  427. Patterns and Predictors of Early Mortality in Incident Hemodialysis Patients: New Insights
  428. Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease
  429. Dialysis Modality and Outcomes in Kidney Transplant Recipients
  430. Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients
  431. Roma ethnicity and clinical outcomes in kidney transplant recipients
  432. Author’s Reply; Visceral Adiposity and not Only Total Body Fat Content Should Be Viewed as a Critical Parameters in Health Prognosis in Renal Failure
  433. Does the Use of mTOR Inhibitors Increase Long-Term Mortality in Kidney Recipients?
  434. Is the Malnutrition-Inflammation Complex the Secret behind Greater Survival of African-American Dialysis Patients?
  435. Association of plasma renin activity and aldosterone–renin ratio with prevalence of chronic kidney disease
  436. Dietary Intake in Hemodialysis Patients Does Not Reflect a Heart Healthy Diet
  437. Novel Lipoprotein Subfraction and Size Measurements in Prediction of Mortality in Maintenance Hemodialysis Patients
  438. Association of Pretransplant Glycemic Control With Posttransplant Outcomes in Diabetic Kidney Transplant Recipients
  439. Serum Erythropoietin Level and Mortality in Kidney Transplant Recipients
  440. Racial and Ethnic Differences in the Association of Body Mass Index and Survival in Maintenance Hemodialysis Patients
  441. Association of Pretransplant Serum Phosphorus with Posttransplant Outcomes
  442. Kardiorenales Anämiesyndrom – Die nephrologische Sichtweise
  443. Serum Albumin as a Predictor of Mortality in Peritoneal Dialysis: Comparisons With Hemodialysis
  444. High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients
  445. Dietary Omega-3 Fatty Acid, Ratio of Omega-6 to Omega-3 Intake, Inflammation, and Survival in Long-term Hemodialysis Patients
  446. Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population
  447. Association of Hemoglobin and Survival in Peritoneal Dialysis Patients
  448. Sarcopenia With Limited Mobility: An International Consensus
  449. Higher recipient body mass index is associated with post-transplant delayed kidney graft function
  450. Assessment of Glycemic Control in Dialysis Patients with Diabetes: Glycosylated Hemoglobin or Glycated Albumin?
  451. Diets and enteral supplements for improving outcomes in chronic kidney disease
  452. Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease
  453. It is not polite to ask a dialysis patient his age!
  454. Design and Development of a Dialysis Food Frequency Questionnaire
  455. AST-120 for preventing progression of chronic kidney disease: What can we conclude from the available evidence?
  456. Quality-of-Life and Mortality in Hemodialysis Patients: Roles of Race and Nutritional Status
  457. Glycemic Control and Survival in Peritoneal Dialysis Patients with Diabetes Mellitus
  458. Erratum to: Wasting in chronic kidney disease
  459. Diuretics and secondary hyperparathyroidism in chronic kidney disease
  460. Associations of Pretransplant Serum Albumin with Post-Transplant Outcomes in Kidney Transplant Recipients
  461. Associations of Body Mass Index and Weight Loss with Mortality in Transplant-Waitlisted Maintenance Hemodialysis Patients
  462. Associations of Pretransplant Weight and Muscle Mass with Mortality in Renal Transplant Recipients
  463. Wasting in chronic kidney disease
  464. An Update on the Comparisons of Mortality Outcomes of Hemodialysis and Peritoneal Dialysis Patients
  465. DIETARY EGG WHITES FOR PHOSPHORUS CONTROL IN MAINTENANCE HAEMODIALYSIS PATIENTS: A PILOT STUDY
  466. Erythropoietin in Kidney Disease and Type 2 Diabetes
  467. Do Anthropometric Indices Accurately Reflect Directly Measured Body Composition in Men and Women With Chronic Heart Failure?
  468. Similar Outcomes With Hemodialysis and Peritoneal Dialysis in Patients With End-Stage Renal Disease
  469. Role of Nutritional Status and Inflammation in Higher Survival of African American and Hispanic Hemodialysis Patients
  470. Insights Into Nutritional and Inflammatory Aspects of Low Parathyroid Hormone in Dialysis Patients
  471. Racial and Ethnic Differences in Mortality of Hemodialysis Patients: Role of Dietary and Nutritional Status and Inflammation
  472. Novel Equations to Estimate Lean Body Mass in Maintenance Hemodialysis Patients
  473. Target Levels for Serum Phosphorus and Parathyroid Hormone
  474. Body Mass Index, Waist Circumference and Mortality in Kidney Transplant Recipients
  475. Peritoneal dialysis: an underutilized modality
  476. The Obesity Paradox and Mortality Associated With Surrogates of Body Size and Muscle Mass in Patients Receiving Hemodialysis
  477. Comparison of Direct Body Composition Assessment Methods in Patients With Chronic Heart Failure
  478. Outcomes Associated With Phosphorus Binders in Men With Non–Dialysis-Dependent CKD
  479. Radiation Exposure in Dialysis Access-Related Procedures Decreases with Increase in Number of Procedures Performed by the Interventional Nephrologist
  480. Survival Disparities within American and Israeli Dialysis Populations: Learning from Similarities and Distinctions across Race and Ethnicity
  481. Mid-Arm Muscle Circumference and Quality of Life and Survival in Maintenance Hemodialysis Patients
  482. National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events
  483. Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis
  484. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study
  485. Activation of caspase-3 in the skeletal muscle during haemodialysis
  486. Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease
  487. Dietary Potassium Intake and Mortality in Long-term Hemodialysis Patients
  488. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals
  489. Dietary Assessment of Individuals with Chronic Kidney Disease
  490. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients
  491. Evaluation of the Malnutrition-Inflammation Score in Kidney Transplant Recipients
  492. Association Between Direct Measures of Body Composition and Prognostic Factors in Chronic Heart Failure
  493. Association of Relatively Low Serum Parathyroid Hormone With Malnutrition-Inflammation Complex and Survival in Maintenance Hemodialysis Patients
  494. Nutritional Recommendations for the Management of Sarcopenia
  495. Epidemiology of Dietary Nutrient Intake in ESRD
  496. Comparing Body Composition Assessment Tests in Long-term Hemodialysis Patients
  497. Association between obesity and health-related quality of life in patients with coronary artery disease
  498. Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients
  499. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD
  500. Glycemic Control and Burnt-Out Diabetes in ESRD
  501. Association of Dietary Phosphorus Intake and Phosphorus to Protein Ratio with Mortality in Hemodialysis Patients
  502. Is There a Role for Intradialytic Parenteral Nutrition? A Review of the Evidence
  503. Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease
  504. Outcomes Associated with Serum Calcium Level in Men with Non-Dialysis-Dependent Chronic Kidney Disease
  505. Association of Cumulatively Low or High Serum Calcium Levels with Mortality in Long-Term Hemodialysis Patients
  506. Association of Hemodialysis Treatment Time and Dose With Mortality and the Role of Race and Sex
  507. Chronic kidney disease: Oral bicarbonate: renoprotective in CKD?
  508. Inflammation in Chronic Kidney Disease
  509. Total and Individual Coronary Artery Calcium Scores as Independent Predictors of Mortality in Hemodialysis Patients
  510. Association of Soluble Endotoxin Receptor CD14 and Mortality Among Patients Undergoing Hemodialysis
  511. IRON THERAPY IN CHRONIC KIDNEY DISEASE: CURRENT CONTROVERSIES
  512. The Obesity Paradox in the Elderly: Potential Mechanisms and Clinical Implications
  513. Clinical Outcomes with Active versus Nutritional Vitamin D Compounds in Chronic Kidney Disease
  514. Ownership Patterns of Dialysis Units and Peritoneal Dialysis in the United States: Utilization and Outcomes
  515. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH
  516. The outcomes of continuous ambulatory and automated peritoneal dialysis are similar
  517. Severity of Hypoalbuminemia Predicts Response to Intradialytic Parenteral Nutrition in Hemodialysis Patients
  518. Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease
  519. Do Genes Allow Inflammation to Kill or Not to Kill?
  520. Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease
  521. Association of Serum Alkaline Phosphatase with Coronary Artery Calcification in Maintenance Hemodialysis Patients
  522. Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
  523. Outcomes Associated with Race in Males with Nondialysis-Dependent Chronic Kidney Disease
  524. Cinacalcet Lowers Serum Alkaline Phosphatase in Maintenance Hemodialysis Patients
  525. Iron and Clinical Outcomes in Dialysis and Non–Dialysis-Dependent Chronic Kidney Disease Patients
  526. Intravenous Iron Versus Erythropoiesis-Stimulating Agents: Friends or Foes in Treating Chronic Kidney Disease Anemia?
  527. Hemoglobin Variability in Anemia of Chronic Kidney Disease
  528. Fluid Retention Is Associated With Cardiovascular Mortality in Patients Undergoing Long-Term Hemodialysis
  529. Association of Malnutrition-Inflammation Score With Quality of Life and Mortality in Hemodialysis Patients: A 5-Year Prospective Cohort Study
  530. Association of Markers of Iron Stores with Outcomes in Patients with Nondialysis-Dependent Chronic Kidney Disease
  531. Is It Worth Correcting Hyperparathyroidism if Hyperphosphatemia and Hypocalcemia Worsen? A Cinacalcet Story
  532. Burnt-Out Diabetes: Impact of Chronic Kidney Disease Progression on the Natural Course of Diabetes Mellitus
  533. Why Is Protein–Energy Wasting Associated With Mortality in Chronic Kidney Disease?
  534. Association of Secondary Hyperparathyroidism with CKD Progression, Health Care Costs and Survival in Diabetic Predialysis CKD Patients
  535. Association of Serum Total Iron-Binding Capacity and Its Changes Over Time with Nutritional and Clinical Outcomes in Hemodialysis Patients
  536. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD
  537. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis
  538. Cachexia: A new definition
  539. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?
  540. Combined High Serum Ferritin and Low Iron Saturation in Hemodialysis Patients: The Role of Inflammation
  541. Serum Alkaline Phosphatase Predicts Mortality among Maintenance Hemodialysis Patients
  542. Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients
  543. Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in Hemodialysis
  544. Glycemic Control in Diabetic CKD Patients: Where Do We Stand?
  545. Response to ‘Secondary hyperparathyroidism is associated with higher mortality in men with mild to moderate CKD’
  546. Serum Ferritin: Deceptively Simple or Simply Deceptive? Lessons Learned From Iron Therapy in Patients With Chronic Kidney Disease
  547. Ratio of Paricalcitol Dosage to Serum Parathyroid Hormone Level and Survival in Maintenance Hemodialysis Patients
  548. Body mass index and mortality in heart failure: A meta-analysis
  549. Malnutrition–Inflammation Score for risk stratification of patients with CKD: is it the promised gold standard?
  550. Nutritional and Anti-Inflammatory Interventions in Chronic Heart Failure
  551. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease
  552. Vitamin D receptor activation and survival in chronic kidney disease
  553. Albumin levels predict survival in patients with systolic heart failure
  554. Bone and mineral disorders in pre-dialysis CKD
  555. Bone and mineral disorders in pre-dialysis CKD
  556. Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease
  557. Association of Activated Vitamin D Treatment and Mortality in Chronic Kidney Disease
  558. A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
  559. Effect of Obesity on Short- and Long-term Mortality Postcoronary Revascularization: A Meta-analysis
  560. Nutritional Therapy in Maintenance Hemodialysis
  561. Battleground: Chronic Kidney Disorders Mineral and Bone Disease Calcium Obsession, Vitamin D, and Binder Confusion
  562. Effects of Sevelamer and Calcium-Based Phosphate Binders on Lipid and Inflammatory Markers in Hemodialysis Patients
  563. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Introduction: The Reverse Epidemiology Controversy
  564. HDL-inflammatory index correlates with poor outcome in hemodialysis patients
  565. Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data?
  566. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: What Is So Bad about Reverse Epidemiology Anyway?
  567. Chronic Peritoneal Dialysis in the United States: Declining Utilization Despite Improving Outcomes
  568. Multicenter Study of the Validity and Reliability of Subjective Global Assessment in the Hemodialysis Population
  569. Racial and survival paradoxes in chronic kidney disease
  570. Serum phosphorus and the risk of progression of chronic kidney disease
  571. Epoetin Dosing and Dialysis Facility Ownership
  572. Inflammatory Marker Mania in Chronic Kidney Disease: Pentraxins at the Crossroad of Universal Soldiers of Inflammation
  573. Obesity Is Associated with Secondary Hyperparathyroidism in Men with Moderate and Severe Chronic Kidney Disease
  574. Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
  575. Risk factor paradox in wasting diseases
  576. So, Is Leptin Good or Bad in Chronic Kidney Disease?
  577. Response to ‘Adynamic Bone Disease and MICS’
  578. Target haemoglobin concentrations in chronic kidney disease
  579. Paradoxical Association Between Body Mass Index and Mortality in Men With CKD Not Yet on Dialysis
  580. Response to ‘Osteodystrophy and dialysis survival’
  581. Reply
  582. Hepatitis C Virus and Death Risk in Hemodialysis Patients
  583. Let's have the next ISN conferences in Havana and Nuremberg
  584. Survival differences between activated injectable vitamin D2 and D3 analogs
  585. A1C and Survival in Maintenance Hemodialysis Patients
  586. Impact of Kidney Bone Disease and Its Management on Survival of Patients on Dialysis
  587. Association between Serum Lipids and Survival in Hemodialysis Patients and Impact of Race
  588. Inverse Association between Lipid Levels and Mortality in Men with Chronic Kidney Disease Who Are Not Yet on Dialysis: Effects of Case Mix and the Malnutrition-Inflammation-Cachexia Syndrome
  589. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation
  590. The kidney disease wasting: Inflammation, oxidative stress, and diet-gene interaction
  591. Hepatitis C inflection in dialysis patients: a link to poor clinical outcome?
  592. The Fascinating but Deceptive Ferritin: To Measure It or Not to Measure It in Chronic Kidney Disease?
  593. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
  594. Longitudinal Associations Between Dietary Protein Intake and Survival in Hemodialysis Patients
  595. Serum Myeloperoxidase and Mortality in Maintenance Hemodialysis Patients
  596. Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease
  597. Body Mass Index and Risk for End-Stage Renal Disease
  598. Fatal hyponatremia in a young woman after ecstasy ingestion
  599. Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients
  600. Epidemiology of Dialysis Patients and Heart Failure Patients
  601. Association of anemia with outcomes in men with moderate and severe chronic kidney disease
  602. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease
  603. If Fat is Good, Muscle is Better
  604. Obesity Paradox in Patients on Maintenance Dialysis
  605. Worth one's salt: the master dysnatremia equation
  606. Association between Serum Bicarbonate and Death in Hemodialysis Patients: Is It Better to Be Acidotic or Alkalotic?
  607. Diagnostic Discordance for Hepatitis C Virus Infection in Hemodialysis: Correlations with Clinical and Laboratory Features
  608. The Latest Addition to the Inflammatory Homeboys in Chronic Kidney Disease: Interleukin-8
  609. Recent Advances in Understanding the Malnutrition-Inflammation-Cachexia Syndrome in Chronic Kidney Disease Patients: What is Next?
  610. The Importance of Origins?
  611. Association of Morbid Obesity and Weight Change Over Time With Cardiovascular Survival in Hemodialysis Population
  612. Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients
  613. Obesity Paradox as a Component of Reverse Epidemiology in Heart Failure
  614. Diagnostic Discordance for Hepatitis C Virus Infection in Hemodialysis Patients
  615. A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls
  616. An Anti-Inflammatory and Antioxidant Nutritional Supplement for Hypoalbuminemic Hemodialysis Patients: A Pilot/Feasibility Study
  617. Kidney insufficiency and nutrient-based modulation of inflammation
  618. Megestrol Acetate in a Moderate Dose for the Treatment of Malnutrition-Inflammation Complex in Maintenance Dialysis Patients
  619. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction
  620. Risks of chronic metabolic acidosis in patients with chronic kidney disease
  621. Health Related Quality of Life in Patients with Chronic Kidney Disease
  622. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study
  623. Reverse epidemiology of blood pressure in dialysis patients
  624. The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: Overview of the NIED study and the role of dietitians
  625. Reverse Epidemiology of Hypertension and Cardiovascular Death in the Hemodialysis Population: The 58th Annual Fall Conference and Scientific Sessions
  626. Causes and consequences of the reverse epidemiology of body mass index in dialysis patients
  627. Reverse Epidemiology: A Spurious Hypothesis or a Hardcore Reality?
  628. POOR NUTRITIONAL STATUS AND INFLAMMATION: Metabolic Acidosis and Malnutrition-Inflammation Complex Syndrome in Chronic Renal Failure
  629. Homocysteine in uraemia--a puzzling and conflicting story
  630. Subjective Global Assessment in chronic kidney disease: A review
  631. Serum Ferritin in Chronic Kidney Disease: Reconsidering the Upper Limit for Iron Treatment
  632. Some notes about the usage of the Charlson co-morbidity index
  633. Inflammation, Cholesterol Levels, and Risk of Mortality Among Patients Receiving Dialysis
  634. Inflammation, Cholesterol Levels, and Risk of Mortality Among Patients Receiving Dialysis
  635. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients
  636. A low serum iron level is a predictor of poor outcome in hemodialysis patients
  637. Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients
  638. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure
  639. A Low, Rather than a High, Total Plasma Homocysteine Is an Indicator of Poor Outcome in Hemodialysis Patients
  640. Relationship between dietary antioxidants and childhood asthma: more epidemiological studies are needed
  641. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients
  642. Reply from the Authors
  643. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences
  644. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients
  645. Reply from the Authors
  646. Inflammation and nutrition in renal insufficiency
  647. Trace elements and vitamins in maintenance dialysis patients
  648. Quality of Care in Profit vs Not-For-Profit Dialysis Centers
  649. Quality of Care in Profit vs Not-For-Profit Dialysis Centers
  650. Diuretics in Critically Ill Patients With Acute Renal Failure
  651. Diuretics in Critically Ill Patients With Acute Renal FailureDiuretics in Critically Ill Patients With Acute Renal Failure
  652. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
  653. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20
  654. Observations with Regard to the National Kidney Foundation K/DOQI Clinical Practice Guidelines Concerning Serum Transthyretin in Chronic Renal Failure
  655. Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire
  656. A Malnutrition-Inflammation Score is correlated with morbidity and mortality in maintenance hemodialysis patients
  657. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients
  658. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients
  659. Near Infra-Red Interactance for Longitudinal Assessment of Nutrition in Dialysis Patients
  660. Diagnosis of Hemochromatosis
  661. Moderately high serum ferritin concentration is not a sign of iron overload in dialysis patients
  662. A modified quantitative subjective global assessment of nutrition for dialysis patients
  663. Near infra-red interactance for nutritional assessment of dialysis patients
  664. Total Iron-Binding Capacity–Estimated Transferrin Correlates With the Nutritional Subjective Global Assessment in Hemodialysis Patients
  665. Diagnosis of iron deficiency in ESRD patients
  666. Nontraumatic bilateral rupture of patellar tendons in a diabetic dialysis patients with secondary hyperparathyroidism
  667. Reply
  668. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era
  669. Protein-Energy Malnutrition
  670. Cachexia in Chronic Kidney Disease: Malnutrition-Inflammation Complex and Reverse Epidemiology